Lineage Cell Therapeutics (LCTX) Total Debt (QoQ) (2014 - 2021)
Lineage Cell Therapeutics (LCTX) Total Debt (QoQ) (2014 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Dec 31, 2017 | -59.09% |
| Sep 30, 2017 | -53.68% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | -20.83% |
| Dec 31, 2016 | -30.64% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | -21.36% |
| Mar 31, 2016 | -10.57% |
| Dec 31, 2015 | -8.21% |
| Sep 30, 2015 | 8,833.33% |
| Jun 30, 2015 | -82.67% |
| Mar 31, 2015 | -44.17% |
| Dec 31, 2014 | -31.05% |
| Sep 30, 2014 | -21.80% |